(2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide

C23H26N10O5 — CID 140511777

IUPAC(2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide
SMILESCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)nc(-c4n[nH]nc4-c4ccncc4)nc32)[C@@H](O)[C@H]1O
InChIInChI=1S/C23H26N10O5/c1-2-25-22(36)18-16(34)17(35)23(38-18)33-10-26-15-20(27-12-5-8-37-9-12)28-19(29-21(15)33)14-13(30-32-31-14)11-3-6-24-7-4-11/h3-4,6-7,10,12,16-18,23,34-35H,2,5,8-9H2,1H3,(H,25,36)(H,27,28,29)(H,30,31,32)/t12-,16-,17+,18+,23-/m1/s1
InChIKeyQVNSOWHYDOPGSE-QHYAINGWSA-N
MW522.53 g/mol
LogP-0.37
Rot. Bonds7

About (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide

(2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide (PubChem CID 140511777) has the molecular formula C23H26N10O5 and a molecular weight of 522.53 g/mol. Its IUPAC name is (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide.

Molecular Properties

Compound Name(2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide
PubChem CID140511777
Molecular FormulaC23H26N10O5
Molecular Weight522.53 g/mol
Exact Mass522.21
IUPAC Name(2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide
SMILESCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)nc(-c4n[nH]nc4-c4ccncc4)nc32)[C@@H](O)[C@H]1O
InChIInChI=1S/C23H26N10O5/c1-2-25-22(36)18-16(34)17(35)23(38-18)33-10-26-15-20(27-12-5-8-37-9-12)28-19(29-21(15)33)14-13(30-32-31-14)11-3-6-24-7-4-11/h3-4,6-7,10,12,16-18,23,34-35H,2,5,8-9H2,1H3,(H,25,36)(H,27,28,29)(H,30,31,32)/t12-,16-,17+,18+,23-/m1/s1
InChIKeyQVNSOWHYDOPGSE-QHYAINGWSA-N
XLogP-0.37
TPSA198.11 Ų
H-Bond Donors5
H-Bond Acceptors13
Rotatable Bonds7
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500522.53
LogP ≤ 5-0.37
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1013

Analyze (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide?
The IUPAC name of (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide (CID 140511777) is (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide.
What is the SMILES notation for (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide?
The canonical SMILES for (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide is CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)nc(-c4n[nH]nc4-c4ccncc4)nc32)[C@@H](O)[C@H]1O.
What is the InChIKey of (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide?
The InChIKey is QVNSOWHYDOPGSE-QHYAINGWSA-N. The full InChI is InChI=1S/C23H26N10O5/c1-2-25-22(36)18-16(34)17(35)23(38-18)33-10-26-15-20(27-12-5-8-37-9-12)28-19(29-21(15)33)14-13(30-32-31-14)11-3-6-24-7-4-11/h3-4,6-7,10,12,16-18,23,34-35H,2,5,8-9H2,1H3,(H,25,36)(H,27,28,29)(H,30,31,32)/t12-,16-,17+,18+,23-/m1/s1.
What are the key properties of (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide?
(2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide has a molecular weight of 522.53 g/mol, XLogP of -0.37, 7 rotatable bonds, 5 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,3R,4S,5R)-N-ethyl-3,4-dihydroxy-5-[6-[[(3R)-oxolan-3-yl]amino]-2-(5-pyridin-4-yl-2H-triazol-4-yl)purin-9-yl]oxolane-2-carboxamide is sourced from PubChem (CID 140511777), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).